TACROLIMUS - ANVISA Registration 80146502080
Access comprehensive regulatory information for TACROLIMUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80146502080 and manufactured by ABBOTT LABORATORIES DIAGNOSTICS DIVISION. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until Feb 26, 2028.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
80146502080
25351407263201798
56998701000116
Company Information
Dates and Status
Feb 26, 2018
26/02/2028
09/18/2025 19:00:01
SIEMENS HEALTHCARE DIAGNOSTICS INCโข United States of America
ROCHE DIAGNOSTICS GMBHโข Germany
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.โข China
ABBOTT IRELAND DIAGNOSTIC DIVISIONโข Ireland
ABBOTT LABORATORIES DIAGNOSTICS DIVISIONโข United States of America
TACROLIMUS
Famรญlia MAGLUMI Tacrolimus (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102513473
Jul 07, 2025
TACROLIMUS
Famรญlia MAGLUMI Tacrolimus (CLIA)
Not specified
80102513473
Jul 07, 2025
TACROLIMUS
Famรญlia MAGLUMI Tacrolimo (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102513199
Feb 26, 2024
TACROLIMUS
Famรญlia MAGLUMI Tacrolimo (CLIA)
Not specified
80102513199
Feb 26, 2024
TACROLIMUS
Famรญlia QMS Tacrolimus
Not specified
80254180462
Jan 02, 2024

